J. F. PANTRIDGE; J. S. GEDDES; S. W. WEBB; A. A. J. ADGEY
This content is PDF only. Please click on the PDF icon to access.
To the editor: In the National Institutes of Health Conference, "The Early Phase of Acute Myocardial Infarction," in the June 1973 issue (Ann Intern Med 78:918-936, 1973), Dr. Epstein and colleagues imply that atropine is not a salutary drug in the acute phase of myocardial infarction.
That paper purports to support these beliefs:  vagally induced bradyarrhythmias do not increase the risk of ventricular dysrhythmias after acute myocardial infarction;  atropine is not of value in suppression of significant ventricular dysrhythmias after acute myocardial infarction;  the prognosis for patients with acute myocardial infarction and untreated sinus bradycardia is good;
PANTRIDGE JF, GEDDES JS, WEBB SW, et al. Atropine and Infarction Bradycardia. Ann Intern Med. 1974;81:125–126. doi: 10.7326/0003-4819-81-1-125
Download citation file:
Published: Ann Intern Med. 1974;81(1):125-126.
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use